However, no study has elucidated the specific molecular mechanisms by which the CXCL12/CXCR4/ACKR3 axis activates the JAK2/STAT3 pathway, and responses to the CXCL12/STAT3 signal transduction may vary across different tumor types and cell lines. This evidence concerns the gene STAT3 and neoplasm.